Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
75,239 questions in 5,342 reviews
current versionsNo studies 15,213 · 20.2%Ungraded 10,323 · 13.7%Very low 17,528 · 23.3%Low 17,951 · 23.9%Moderate 11,190 · 14.9%High 3,034 · 4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic Function ‐ not measured · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic Harms · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic Headache ( · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | RR 31.003 [1.96, 490.31] | 1 study · 48 participants | Very low |
Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic Injection site pain ( · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | RR 0.11 [0.01, 1.96] | 1 study · 48 participants | Very low |
Summary of findings: 5 mg/day vs placebo Adjusted pain intensity Visual Analog Scale. Scale from: 0 to 10. ( · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | no estimate extracted | 1 study · 20 participants | Low |
Summary of findings: 5 mg/day vs placebo Symptom free ( · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | RR 1.91 [1.04, 3.5] | 1 study · 20 participants | Very low |
Summary of findings: 5 mg/day vs placebo Function ‐ not measured · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: 5 mg/day vs placebo Harms · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: 5 mg/day vs placebo Headache ‐ not reported4 · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation Benefits · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation Pain ‐ not reported1 · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation Symptom free with activities of daily living (patient rated) ( · People with rotator cuff disease Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane | RR 1.92 [0.92, 4.1] | 1 study · 57 participants | Low |
Intervention NR Mortality (0 to 26 months) · Haemopoietic stem cell donors Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy… (2009) · Cochrane | RR 0.25 [0.05, 2.15] | 3 studies · 189 participants | Moderate |
Intervention NR Adverse events (day 7 to day 30 post‐donation) · Haemopoietic stem cell donors Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy… (2009) · Cochrane | no estimate extracted | 6 studies · 656 participants | Low |
Intervention NR Pain subsequent to donation ("after collection" ‐ day 30 post‐donation) · Haemopoietic stem cell donors Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy… (2009) · Cochrane | no estimate extracted | 6 studies · 656 participants | Low |
Intervention NR Psychological morbidity (immediately ‐ day 28 post‐donation) · Haemopoietic stem cell donors Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy… (2009) · Cochrane | no estimate extracted | 3 studies · 214 participants | Low |
Eye drop dispenser device vs standard bottle Difficulty squeezing out drops · patients with rheumatoid arthritis Assistive technology for rheumatoid arthritis (2009) · Cochrane | RR 0.22 [0.06, 0.62] | 1 study · 58 participants | Low |
Eye drop dispenser device vs standard bottle Difficulty getting drops into eyes · patients with rheumatoid arthritis Assistive technology for rheumatoid arthritis (2009) · Cochrane | RR 0.27 [0.1, 0.71] | 1 study · 58 participants | Low |
Eye drop dispenser device vs standard bottle Difficulty squeezing bottle · patients with rheumatoid arthritis Assistive technology for rheumatoid arthritis (2009) · Cochrane | RR 0.56 [0.31, 0.99] | 1 study · 58 participants | Low |
Eye drop dispenser device vs standard bottle Difficulty controlling the number of drops · patients with rheumatoid arthritis Assistive technology for rheumatoid arthritis (2009) · Cochrane | RR 0.61 [0.37, 1] | 1 study · 50 participants | Low |
Eye drop dispenser device vs standard bottle Difficulty aiming drops · patients with rheumatoid arthritis Assistive technology for rheumatoid arthritis (2009) · Cochrane | RR 0.6 [0.37, 0.98] | 1 study · 49 participants | Low |
Eye drop dispenser device vs standard bottle Device usability · patients with rheumatoid arthritis Assistive technology for rheumatoid arthritis (2009) · Cochrane | no estimate extracted | 1 study · 58 participants | Ungraded |
Eye drop dispenser device vs standard bottle Adverse events ‐ Touching the eye with the bottle tip · patients with rheumatoid arthritis Assistive technology for rheumatoid arthritis (2009) · Cochrane | RR 0.01 [0, 0.1] | 1 study · 58 participants | Low |
Intervention NR All‐cause mortality at 2 days ‐ immediate treatment · patients with acute myocardial infarction1 Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an… (2009) · Cochrane | RR 0.81 [0.74, 0.89] | 6 studies · 82624 participants | High |
Intervention NR All‐cause mortality at 10 days‐ short‐term treatment · patients with acute myocardial infarction1 Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an… (2009) · Cochrane | RR 0.91 [0.86, 0.97] | 6 studies · 78178 participants | High |
Intervention NR All‐cause mortality at 2 days ‐ immediate treatment · acute myocardial infarction1 Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an… (2009) · Cochrane | RR 0.91 [0.82, 1] | 3 studies · 77414 participants | High |
Intervention NR All‐cause mortality at 10 days ‐ short‐term treatment · acute myocardial infarction1 Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an… (2009) · Cochrane | RR 0.93 [0.87, 0.98] | 10 studies · 84311 participants | High |
Intervention NR All‐cause mortality at 2 days ‐ immediate treatment · patients with acute myocardial infarction1 Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an… (2009) · Cochrane | RR 0.95 [0.85, 1.07] | 6 studies · 68007 participants | Low |
Intervention NR All‐cause mortality at 10 days ‐ short‐term treatment · patients with acute myocardial infarction1 Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an… (2009) · Cochrane | RR 0.96 [0.91, 1.02] | 14 studies · 71457 participants | High |
Intervention NR All‐cause mortality at 2 days ‐ immediate treatment · patients with acute myocardial infarction or stroke1 Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an… (2009) · Cochrane | RR 2.33 [0.62, 8.78] | 3 studies · 242 participants | Very low |
Intervention NR All‐cause mortality at 10 days ‐ short‐term treatment · patients with acute myocardial infarction or stroke1 Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an… (2009) · Cochrane | RR 1.01 [0.73, 1.38] | 15 studies · 1900 participants | Very low |
Intervention NR Functional ability HAQ . Scale from: 0 to 3. · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 1 study · 50 participants | Moderate |
Intervention NR Disease activity · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 0 studies · 3 participants | Low |
Intervention NR Radiological damage ‐ not measured · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Functional ability outcome was measured on different scales in different studies · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 2 studies · 88 participants | Moderate |
Intervention NR Muscle strenght Grip strength · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 1 study · 20 participants | Low |
Intervention NR Self‐reported pain AIMS. Scale from: 0 to 10. · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 1 study · 68 participants | Moderate |
Intervention NR Disease activity · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 2 studies · 88 participants | Moderate |
Intervention NR Radiological damage ‐ not measured · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Small patient number · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 1 participants | Ungraded |
Intervention NR Functional ability outcome was measured on different scales in different studies · patients with patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 2 studies · 305 participants | High |
Intervention NR Muscle strength Isometric extension · patients with patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 2 studies · 305 participants | High |
Intervention NR Muscle strength Isometric extension · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 2 studies · 74 participants | Moderate |
Intervention NR Self‐reported pain VAS. Scale from: 0 to 10. · patients with patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 1 study · 24 participants | Low |
Intervention NR Disease activity DAS · patients with patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 1 study · 281 participants | High |
Intervention NR Radiological damage Joint score radiographics · patients with patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 2 studies · 305 participants | High |
Intervention NR Small patient number · patients with patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 1 participants | Ungraded |
Intervention NR Self‐reported pain VAS. Scale from: 0 to 10. · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 1 study · 50 participants | Moderate |
Intervention NR Disease activity · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | 2 studies · 74 participants | Moderate |
Intervention NR Radiological damage ‐ not measured · patients with Rheumatoid Arthritis Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid… (2009) · Cochrane | no estimate extracted | NR | No studies |